Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) vs CRS alone for treatment of endometrial cancer with peritoneal metastases: a multi-institutional study from PSOGI and BIG RENAPE groups

Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) vs CRS alone for treatment of endometrial cancer with peritoneal metastases: a multi-institutional study from PSOGI and BIG RENAPE groups

Abstract Objective To investigate the benefit of cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of endometrial peritoneal carcinomatosis compared to CRS alone. Methods We conducted a retrospective multicentre study of patients from exper...

Full description

Bibliographic Details
Main Authors: Manuel Gomes David, Naoual Bakrin, Julia Salleron, Marie Christine Kaminsky, Jean Marc Bereder, Jean Jacques Tuech, Kuno Lehmann, Sanket Mehta, Olivier Glehen, Frédéric Marchal
Format: Article
Language:English
Published: BMC 2022-01-01
Series:BMC Surgery
Subjects:
HIPEC
Endometrial cancer
Carcinomatosis
Cytoreductive surgery
Peritoneal metastasis
Online Access:https://doi.org/10.1186/s12893-021-01449-z

Internet

https://doi.org/10.1186/s12893-021-01449-z

Similar Items